Development of a novel measure of advanced cancer patients’ perceived utility of secondary germline findings from tumor genomic profiling

OBJECTIVE: Tumor genomic profiling (TGP) can inform advanced cancer patients’ treatment decisions, and also reveal secondary germline findings—information about inherited risks for cancer and other disorders. We sought to develop a measure of patient perceptions of the clinical and personal utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamilton, Jada G., Shah, Ibrahim H., Salafia, Caroline, Schofield, Elizabeth, Garzon, Margaux Genoff, Cadet, Kechna, Stadler, Zsofia K., Hay, Jennifer L., Offit, Kenneth, Robson, Mark E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles from Special issue on Communication in Genomic and Precision Medicine; Edited by Gemme Campbell-Salome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194097/
https://www.ncbi.nlm.nih.gov/pubmed/37214538
http://dx.doi.org/10.1016/j.pecinn.2023.100124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10194097/
https://www.ncbi.nlm.nih.gov/pubmed/37214538
http://dx.doi.org/10.1016/j.pecinn.2023.100124

Ejemplares similares